FGC
EBS icon

Financial Gravity Companies’s Emergent Biosolutions EBS Stock Holding History

Financial Gravity Companies’s Portfolio EBS Stock Details EBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		$204K Buy
+3,250
New +$210K 0.19% 125
2018
Q1 		$190K Buy
3,719
+1,300
+54% +$64.8K 0.19% 104
2017
Q4 		$118K Buy
+2,419
New +$102K 0.14% 153

Other funds holding EBS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
SCM
Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Financial Gravity Companies's EBS Position: Q4 2018 in Review

Financial Gravity Companies opened a new position in Emergent Biosolutions (EBS) in Q4 2018: 3,250 shares worth $204K. The stake represents 0.19% of the portfolio and ranks #125 among its holdings. This is a return to the name: Financial Gravity Companies previously reported a position in EBS as recently as Q1 2018.

Financial Gravity Companies first reported a position in EBS in Q4 2017 and has held it in 3 quarters since. 297 funds tracked by Wall St. Rank hold EBS as of Q4 2018.

  • Financial Gravity Companies held 3,250 shares of Emergent Biosolutions worth $204K as of Q4 2018.
  • Emergent Biosolutions was a new Financial Gravity Companies position in Q4 2018.
  • Emergent Biosolutions made up 0.19% of Financial Gravity Companies's portfolio in Q4 2018, its #125 holding.
  • Financial Gravity Companies first reported a position in Emergent Biosolutions in Q4 2017 and has held it in 3 quarters since.
  • 297 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q4 2018.

Based on Financial Gravity Companies's 13F filing for Q4 2018, filed 4 Feb 2019.